BEAM
Price
$16.80
Change
-$0.34 (-1.98%)
Updated
Jun 27 closing price
Capitalization
1.69B
44 days until earnings call
GLPG
Price
$27.98
Change
+$0.27 (+0.97%)
Updated
Jun 27 closing price
Capitalization
1.84B
24 days until earnings call
Interact to see
Advertisement

BEAM vs GLPG

Header iconBEAM vs GLPG Comparison
Open Charts BEAM vs GLPGBanner chart's image
Beam Therapeutics
Price$16.80
Change-$0.34 (-1.98%)
Volume$4.49M
Capitalization1.69B
Galapagos
Price$27.98
Change+$0.27 (+0.97%)
Volume$183.09K
Capitalization1.84B
BEAM vs GLPG Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. GLPG commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and GLPG is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BEAM: $16.80 vs. GLPG: $27.98)
Brand notoriety: BEAM and GLPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 238% vs. GLPG: 49%
Market capitalization -- BEAM: $1.69B vs. GLPG: $1.84B
BEAM [@Biotechnology] is valued at $1.69B. GLPG’s [@Biotechnology] market capitalization is $1.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while GLPG’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • GLPG’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +0.18% price change this week, while GLPG (@Biotechnology) price change was +2.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

GLPG is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.84B) has a higher market cap than BEAM($1.69B). GLPG YTD gains are higher at: 1.745 vs. BEAM (-32.258). GLPG has higher annual earnings (EBITDA): -127.75M vs. BEAM (-399.03M). GLPG has more cash in the bank: 3.3B vs. BEAM (1.22B). GLPG has less debt than BEAM: GLPG (10.9M) vs BEAM (158M). GLPG has higher revenues than BEAM: GLPG (288M) vs BEAM (63.6M).
BEAMGLPGBEAM / GLPG
Capitalization1.69B1.84B92%
EBITDA-399.03M-127.75M312%
Gain YTD-32.2581.745-1,848%
P/E RatioN/A54.80-
Revenue63.6M288M22%
Total Cash1.22B3.3B37%
Total Debt158M10.9M1,450%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMGLPG
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
60%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AINIX17.270.13
+0.76%
Ariel International Institutional
HRIDX14.250.09
+0.64%
Harbor Diversified Intl All Cp Admin
WFPRX48.190.06
+0.12%
Allspring Special Mid Cap Value R6
EMAYX17.400.01
+0.06%
Gabelli Entpr Mergers & Acquisitions Y
ABSIX20.070.01
+0.05%
AB Discovery Value I

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.98%
CRSP - BEAM
72%
Closely correlated
N/A
RXRX - BEAM
64%
Loosely correlated
-6.85%
NTLA - BEAM
63%
Loosely correlated
-0.52%
DNLI - BEAM
61%
Loosely correlated
-2.69%
SYRE - BEAM
59%
Loosely correlated
-4.99%
More

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with RGNX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.97%
RGNX - GLPG
37%
Loosely correlated
-4.11%
BEAM - GLPG
36%
Loosely correlated
-1.98%
CRSP - GLPG
34%
Loosely correlated
N/A
NTLA - GLPG
34%
Loosely correlated
-0.52%
RPRX - GLPG
34%
Loosely correlated
+1.76%
More